DEA; March 6, 2023
Tag: DEA
DEA Tox – Quarterly Report – 4th Quarter
Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I
Summary of Validated Quantitative Methods
DEA; 40pp; December 2022
Summary of Validated Qualitative Methods
Drugs of Abuse – A DEA Resource Guide – 2022 Edition
DEA Tox – Toxicology Testing Program
DEA; Third Quarter; 2022
Schedules of Controlled Substances: Placement of Mesocarb in Schedule I
DEA; November 22, 2022
Schedules of Controlled Substances: Placement of Zipeprol in Schedule I
DEA; November 21, 2022
Schedules of Controlled Substances: Placement of Amineptine in Schedule I
DEA; November 17, 2022
Schedules of Controlled Substances: Placement of Daridorexant in Schedule IV
DEA; September 30, 2022
NFLIS-Drug Snapshot
National Forensic Laboratory Information System
DEA Tox – Quarterly Report – 2nd Quarter
Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV
DEA; June 24, 2022
Schedules of Controlled Substances: Placement of Methoxetamine (MXE) in Schedule I\Drug
DEA; June 6, 2022
Schedules of Controlled Substances: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4′-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4′-Chloro-alpha-pyrrolidinovalerophenone in Schedule I
DEA; June 1, 2022
Schedules of Controlled Substances: Placement of Ganaxolone in Schedule V
DEA; June 1, 2022
DEA TOX: Quarterly Report – 1st Quarter 2022
DEA; May 2022
NFLIS-Drug 2021 midyear report
National Forensic Laboratory Information System, Diversion Control Division
DEA; 32pp; April 2022
Synth-Opioids Real-Time Communication Network – 2021 annual report
Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I
DEA; April 11, 2022
Schedules of Controlled Substances: Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I; Final rule
DEA; April 7, 2022
DEA TOX: Quarterly Report – 4th Quarter 2021
U.S. Drug Enforcement Administration, Diversion Control Division, 2022
NFLIS-Drug Special Report: Gabapentin and Pregabalin Reported in NFLIS, 2011–2020
Emoji Drug Code Decoded
Drug Enforcement Administration; January 2022
Schedules of Controlled Substances: Placement of Methoxetamine (MXE) in Schedule I
Drug Enforcement Administration; December 7, 2021
Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I
Drug Enforcement Administration; December 7, 2021
Designation of Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine, as a List I Chemical
Drug Enforcement Administration, Department of Justice
Document Number 2021-24952, 86 FR 64362, pp 64362-64366, November 18, 2021
NFLIS-Drug 2020 Annual Report
U.S. Department of Justice, U.S. Drug Enforcement Administration, Diversion Control Division
National Forensic Laboratory Information System; 36pp; 2021
Emerging Threat Report; Mid-Year 2021
Special Testing and Research Laboratory
Drug Enforcement Administration; October 2021
Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I
Drug Enforcement Administration; November 4, 2021
Download final rule
Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I
Drug Enforcement Administration
Department of Justice; September 2, 2021
Download Federal Register notification here
Laboratory Operations Manual
Office of Forensic Sciences
Drug Enforcement Administration; 269 pages; 2021
Download the manual here
Schedules of Controlled Substances: Placement of Mesocarb in Schedule I
Drug Enforcement Administration; Department of Justice; August 11, 2021
Download the ruling from the Federal Register
The Drug Enforcement Administration proposes placing the substance mesocarb (chemical name: N-phenyl-N′-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act.